pharma-company /Medicinal products /Active ingredients

Rx · PZN 10395152

LEVODOPA-Carbidopa AbZ 200-50 mg prolonged-release tablets

German trade nameLEVODOPA Carbidopa AbZ 200-50 mg Retardtabletten

Active ingredientLevodopa and decarboxylase inhibitorSubstance (DE)Levodopa und Decarboxylasehemmer*Pharmaceutical formProlonged-release tablets

Available with fluctuations

4.4

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026

Highest known
purchase price (B2B)

~ €39

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is a rounded approximation. We are happy to advise you on your terms for LEVODOPA-Carbidopa AbZ 200-50 mg prolonged-release tablets.

Review purchasing terms

LEVODOPA-Carbidopa AbZ 200-50 mg prolonged-release tablets contains the active ingredient Levodopa and decarboxylase inhibitor (German Levodopa und Decarboxylasehemmer*) and comes as Prolonged-release tablets. One pack size is recorded (PZN 10395152). The pharma availability index for German wholesale stands at 4.4 out of 10 over the past 30 days – the pack was therefore available with fluctuations.

Availability of LEVODOPA-Carbidopa AbZ 200-50 mg prolonged-release tablets fluctuates noticeably. We are happy to advise you on securing your supply through additional sources.

Secure your supply

More products containing Levodopa and decarboxylase inhibitor

DOPADURA C 100-25 mg retard tablets9.6ISICOM 100 mg/25 mg tablets9.6ISICOM 250 mg/25 mg tablets9.6LEVOCARB 100-25 ret-1A Pharma prolonged-release tablets9.6LEVOCARB 100-25-1A Pharma tablets9.6
All 79 products containing Levodopa and decarboxylase inhibitor →

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. One PZN is recorded for this product; the stated purchase price refers to it.